BioPacificVentures is one of the world's largest food, nutrition and agriculturally focused venture capitalists, specialising in the convergence of food and health with a focus on prevention, nutrition, food technology and agbiotech.
BioPacificVentures pursues attractive life science investment opportunities with an Australasian focus and takes lead or co-investment positions in rounds ranging from NZ$2 to NZ$10 million.
BioPacificVentures is supported by strategic and financial investors with global reach and industry specific expertise. The largest investor is the world’s biggest food company, Nestlé; the largest local investor is the leading agribusiness firm PGG Wrightson.
While investments are made across the whole life science spectrum, BioPacificVentures has a particular focus on opportunities in the emerging "wellness through prevention" market, reflecting the increasing trend in healthcare towards the prevention of chronic diseases. Opportunities of particular interest include functional and medical foods, nutraceuticals, cosmeceuticals, skin care, dietary supplements, infant and sports nutrition, immune stimulation and anti-aging therapies.
BioPacificVentures has a strong internationally experienced management team, the result of a collaboration between leading New Zealand venture capital firm Direct Capital, international life sciences venture capital manager, inventages and AgResearch.